{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T09:52:51Z","timestamp":1711619571944},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00415-010-5689-y","type":"journal-article","created":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T03:18:18Z","timestamp":1280978298000},"page":"1590-1593","source":"Crossref","is-referenced-by-count":10,"title":["Advances in multiple sclerosis research in 2009"],"prefix":"10.1007","volume":"257","author":[{"given":"Stefan","family":"Nessler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Br\u00fcck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,6]]},"reference":[{"key":"5689_CR1","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00415-009-5171-x","volume":"256","author":"E Bizzoco","year":"2009","unstructured":"Bizzoco E, Lolli F, Repice AM, Hakiki B, Falcini M, Barilaro A, Taiuti R, Siracusa G, Amato MP, Biagioli T, Lori S, Moretti M, Vinattieri A, Nencini P, Massacesi L, Mata S (2009) Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol 256:1891\u20131898","journal-title":"J Neurol"},{"key":"5689_CR2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00415-009-0009-0","volume":"256","author":"JA Cabrera-Gomez","year":"2009","unstructured":"Cabrera-Gomez JA, Kurtzke JF, Gonzalez-Quevedo A, Lara-Rodriguez R (2009) An epidemiological study of neuromyelitis optica in Cuba. J Neurol 256:35\u201344","journal-title":"J Neurol"},{"key":"5689_CR3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00415-009-5047-0","volume":"256","author":"A Conte","year":"2009","unstructured":"Conte A, Lenzi D, Frasca V, Gilio F, Giacomelli E, Gabriele M, Bettolo CM, Iacovelli E, Pantano P, Pozzilli C, Inghilleri M (2009) Intracortical excitability in patients with relapsing\u2013remitting and secondary progressive multiple sclerosis. J Neurol 256:933\u2013938","journal-title":"J Neurol"},{"key":"5689_CR4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s00415-009-5016-7","volume":"256","author":"C Fenoglio","year":"2009","unstructured":"Fenoglio C, Scalabrini D, Piccio L, De RM, Venturelli E, Cortini F, Villa C, Serpente M, Parks B, Rinker J, Cross AH, Bresolin N, Scarpini E, Galimberti D (2009) Candidate gene analysis of selectin cluster in patients with multiple sclerosis. J Neurol 256:832\u2013833","journal-title":"J Neurol"},{"key":"5689_CR5","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00415-009-5223-2","volume":"256","author":"O Fernandez","year":"2009","unstructured":"Fernandez O, Antiguedad A, Pinto-Medel MJ, Mendibe MM, Acosta N, Oliver B, Guerrero M, Papais-Alvarenga M, Fernandez-Sanchez V, Leyva L (2009) HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque country, Spain). J Neurol 256:1977\u20131988","journal-title":"J Neurol"},{"key":"5689_CR6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-009-0110-4","volume":"256","author":"T Hayton","year":"2009","unstructured":"Hayton T, Furby J, Smith KJ, Altmann DR, Brenner R, Chataway J, Hughes RA, Hunter K, Tozer DJ, Miller DH, Kapoor R (2009) Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis. J Neurol 256:427\u2013435","journal-title":"J Neurol"},{"key":"5689_CR7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00415-009-0093-1","volume":"256","author":"M Hutchinson","year":"2009","unstructured":"Hutchinson M, Kappos L, Calabresi PA, Confavreux C, Giovannoni G, Galetta SL, Havrdova E, Lublin FD, Miller DH, O\u2019Connor PW, Phillips JT, Polman CH, Radue EW, Rudick RA, Stuart WH, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA (2009) The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL. J Neurol 256:405\u2013415","journal-title":"J Neurol"},{"key":"5689_CR8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00415-009-5081-y","volume":"256","author":"HB Huttner","year":"2009","unstructured":"Huttner HB, Schellinger PD, Struffert T, Richter G, Engelhorn T, Bassemir T, Maurer M, Garcia M, Schwab S, Kohrmann M, Doerfler A (2009) MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof\u2019s criteria but different lesion patterns. J Neurol 256:1121\u20131125","journal-title":"J Neurol"},{"key":"5689_CR9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00415-009-0084-2","volume":"256","author":"FR Johnson","year":"2009","unstructured":"Johnson FR, Van HG, Ozdemir S, Hass S, White J, Francis G, Miller DW, Phillips JT (2009) Multiple sclerosis patients\u2019 benefit\u2013risk preferences: serious adverse event risks versus treatment efficacy. J Neurol 256:554\u2013562","journal-title":"J Neurol"},{"key":"5689_CR10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00415-009-0152-7","volume":"256","author":"R Lange","year":"2009","unstructured":"Lange R, Volkmer M, Heesen C, Liepert J (2009) Modafinil effects in multiple sclerosis patients with fatigue. J Neurol 256:645\u2013650","journal-title":"J Neurol"},{"key":"5689_CR11","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00415-009-5170-y","volume":"256","author":"J Massa","year":"2009","unstructured":"Massa J, O\u2019Reilly E, Munger KL, Delorenze GN, Ascherio A (2009) Serum uric acid and risk of multiple sclerosis. J Neurol 256:1643\u20131648","journal-title":"J Neurol"},{"key":"5689_CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00415-009-0075-3","volume":"256","author":"JE Merrill","year":"2009","unstructured":"Merrill JE, Hanak S, Pu SF, Liang J, Dang C, Iglesias-Bregna D, Harvey B, Zhu B, McMonagle-Strucko K (2009) Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis. J Neurol 256:89\u2013103","journal-title":"J Neurol"},{"key":"5689_CR13","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00415-009-5225-0","volume":"256","author":"UM Messmer","year":"2009","unstructured":"Messmer UM, Specchia C, Battaglia MA, Miller DM (2009) Factors that influence the employment status of people with multiple sclerosis: a multi-national study. J Neurol 256:1989\u20131996","journal-title":"J Neurol"},{"key":"5689_CR14","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00415-009-5074-x","volume":"256","author":"SA Morrow","year":"2009","unstructured":"Morrow SA, Kaushik T, Zarevics P, Erlanger D, Bear MF, Munschauer FE, Benedict RH (2009) The effects of l-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial. J Neurol 256:1095\u20131102","journal-title":"J Neurol"},{"key":"5689_CR15","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00415-009-5063-0","volume":"256","author":"EM Mowry","year":"2009","unstructured":"Mowry EM, Pesic M, Grimes B, Deen SR, Bacchetti P, Waubant E (2009) Clinical predictors of early second event in patients with clinically isolated syndrome. J Neurol 256:1061\u20131066","journal-title":"J Neurol"},{"key":"5689_CR16","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s00415-009-5139-x","volume":"256","author":"C Pierrot-Deseilligny","year":"2009","unstructured":"Pierrot-Deseilligny C (2009) Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol 256:1468\u20131479","journal-title":"J Neurol"},{"key":"5689_CR17","doi-asserted-by":"crossref","unstructured":"Pittas F, Ponsonby AL, van der Mei IA, Taylor BV, Blizzard L, Groom P, Ukoumunne OC, Dwyer T (2009) Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. J Neurol 256:577\u2013585","DOI":"10.1007\/s00415-009-0120-2"},{"key":"5689_CR18","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1007\/s00415-009-5257-5","volume":"256","author":"K Stuke","year":"2009","unstructured":"Stuke K, Flachenecker P, Zettl UK, Elias WG, Freidel M, Haas J, Pitschnau-Michel D, Schimrigk S, Rieckmann P (2009) Symptomatology of MS: results from the German MS Registry. J Neurol 256:1932\u20131935","journal-title":"J Neurol"},{"key":"5689_CR19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00415-009-0096-y","volume":"256","author":"K Treadaway","year":"2009","unstructured":"Treadaway K, Cutter G, Salter A, Lynch S, Simsarian J, Corboy J, Jeffery D, Cohen B, Mankowski K, Guarnaccia J, Schaeffer L, Kanter R, Brandes D, Kaufman C, Duncan D, Marder E, Allen A, Harney J, Cooper J, Woo D, Stuve O, Racke M, Frohman EM (2009) Factors that influence adherence with disease-modifying therapy in MS. J Neurol 256:568\u2013576","journal-title":"J Neurol"},{"key":"5689_CR20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00415-009-0039-7","volume":"256","author":"H Tremlett","year":"2009","unstructured":"Tremlett H, Zhao Y, Devonshire V (2009) Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities. J Neurol 256:374\u2013381","journal-title":"J Neurol"},{"key":"5689_CR21","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1007\/s00415-009-5274-4","volume":"256","author":"A Uzawa","year":"2009","unstructured":"Uzawa A, Mori M, Ito M, Uchida T, Hayakawa S, Masuda S, Kuwabara S (2009) Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis. J Neurol 256:2082\u20132084","journal-title":"J Neurol"},{"key":"5689_CR22","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00415-009-5123-5","volume":"256","author":"MT Wallin","year":"2009","unstructured":"Wallin MT, Page WF, Kurtzke JF (2009) Migration and multiple sclerosis in Alaskan military veterans. J Neurol 256:1413\u20131417","journal-title":"J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00415-010-5689-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T23:28:00Z","timestamp":1551569280000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-010-5689-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,6]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["5689"],"URL":"https:\/\/doi.org\/10.1007\/s00415-010-5689-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,6]]}}}